Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes.

Saved in:
Bibliographic Details
Title: Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes.
Authors: Mathieu C; Katholieke Universiteit Leuven, Leuven, Belgium chantal.mathieu@med.kuleuven.be., Ranetti AE; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Li D; Bristol-Myers Squibb, Princeton, NJ., Ekholm E; AstraZeneca, Molndal, Sweden., Cook W; AstraZeneca, Gaithersburg, MD., Hirshberg B; MedImmune, Gaithersburg, MD., Chen H; AstraZeneca, Gaithersburg, MD., Hansen L; Bristol-Myers Squibb, Princeton, NJ., Iqbal N; Bristol-Myers Squibb, Princeton, NJ.
Source: Diabetes care [Diabetes Care] 2015 Nov; Vol. 38 (11), pp. 2009-17. Date of Electronic Publication: 2015 Aug 05.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 26246458
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mathieu+C%22">Mathieu C</searchLink>; Katholieke Universiteit Leuven, Leuven, Belgium chantal.mathieu@med.kuleuven.be.<br /><searchLink fieldCode="AU" term="%22Ranetti+AE%22">Ranetti AE</searchLink>; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.<br /><searchLink fieldCode="AU" term="%22Li+D%22">Li D</searchLink>; Bristol-Myers Squibb, Princeton, NJ.<br /><searchLink fieldCode="AU" term="%22Ekholm+E%22">Ekholm E</searchLink>; AstraZeneca, Molndal, Sweden.<br /><searchLink fieldCode="AU" term="%22Cook+W%22">Cook W</searchLink>; AstraZeneca, Gaithersburg, MD.<br /><searchLink fieldCode="AU" term="%22Hirshberg+B%22">Hirshberg B</searchLink>; MedImmune, Gaithersburg, MD.<br /><searchLink fieldCode="AU" term="%22Chen+H%22">Chen H</searchLink>; AstraZeneca, Gaithersburg, MD.<br /><searchLink fieldCode="AU" term="%22Hansen+L%22">Hansen L</searchLink>; Bristol-Myers Squibb, Princeton, NJ.<br /><searchLink fieldCode="AU" term="%22Iqbal+N%22">Iqbal N</searchLink>; Bristol-Myers Squibb, Princeton, NJ.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227805975%22">Diabetes care</searchLink> [Diabetes Care] 2015 Nov; Vol. 38 (11), pp. 2009-17. <i>Date of Electronic Publication: </i>2015 Aug 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Diabetes+Association%22">American Diabetes Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7805975 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1935-5548 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201495992%22">01495992 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Care <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26246458
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2337/dc15-0779
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2009
    Titles:
      – TitleFull: Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mathieu C
      – PersonEntity:
          Name:
            NameFull: Ranetti AE
      – PersonEntity:
          Name:
            NameFull: Li D
      – PersonEntity:
          Name:
            NameFull: Ekholm E
      – PersonEntity:
          Name:
            NameFull: Cook W
      – PersonEntity:
          Name:
            NameFull: Hirshberg B
      – PersonEntity:
          Name:
            NameFull: Chen H
      – PersonEntity:
          Name:
            NameFull: Hansen L
      – PersonEntity:
          Name:
            NameFull: Iqbal N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2015 Nov
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-electronic
              Value: 1935-5548
          Numbering:
            – Type: volume
              Value: 38
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Diabetes care
              Type: main
ResultId 1